Abbott Laboratories Market Share Analysis

Introduction

GlobalData’s medical devices report, “Abbott Laboratories Market Share Analysis” provides in-depth information on Abbott’s market position in the different medical equipment markets it operates in. The report provides Abbott’s market share information in nine key market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Interventional Cardiology, Peripheral Vascular Devices, and Glucose Monitoring. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Abbott operates in – In Vitro Diagnostics (IVD), Cardiovascular Devices and Diabetes Care Devices. Other Key players covered include F. Hoffmann-La Roche, Siemens Healthcare, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson and Company (BD), Medtronic, Boston Scientific Corporation, St. Jude Medical, Cordis, Terumo Corporationa, and LifeScan among others.
- Abbott’s company shares (in Revenues) information for all the key countries the company has presence in – United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Abbott’s company shares (in Revenues) information for all the key market categories the company has presence in – Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Interventional Cardiology, Peripheral Vascular Devices, and Glucose Monitoring.
- All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), South Central America (SCA), and Middle East and Africa (MEA).
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Highlights

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Abbott operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Abbott’s market positions.

Report Highlights
Animas Corporation
ARKRAY, Inc.
Bayer HealthCare AG
Beckman Coulter, Inc.
Becton, Dickinson and Company
Biomerieux Sa
Bio-Rad Laboratories, Inc.
Biosense Webster, Inc.
BIOTRONIK SE & Co. KG
Boehringer Ingelheim GmbH
Boston Scientific Corporation
C.R. Bard, Inc.
Cordis Corporation
DiaSorin S.p.A
Edwards Lifesciences Corporation
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gen-Probe Incorporated
Guidant Corp.
Inverness Medical Innovations, Inc.
LifeScan, Inc.
Medtronic, Inc.
Novo Nordisk A/S
Olympus Medical Systems Corp.
Ortho-Clinical Diagnostics Inc.
Philips Healthcare
Qiagen N.V.
Sanofi-Aventis
Siemens Healthcare
Sorin Group
St. Jude Medical, Inc.
Sysmex Corporation
Terumo Corporation
[Studien Infos ausblenden]

TABLE OF CONTENTS

1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of Markets/Categories Covered 15
3.1 In Vitro Diagnostics 15
3.1.1 Clinical Chemistry 15
3.1.2 Genetic Testing 15
3.1.3 Haematology 15
3.1.4 Histology and Cytology 15
3.1.5 Immuno Chemistry 15
3.1.6 Infectious Immunology 15
3.2 Cardiovascular Devices 16
3.2.1 Interventional Cardiology 16
3.2.2 Peripheral Vascular Devices 16
3.3 Diabetes Care Devices 16
3.3.1 Glucose Monitoring 16
4 Company Snapshot 17
4.1 Key Information 17
4.2 Company Overview 17
4.3 Financial Performance 17
4.4 SWOT Snapshot 17
5 Business Description 18
5.1 Business Overview 18
5.2 Diagnostics 18
5.2.1 Overview 18
5.2.2 Financials 18
5.2.3 Market View 18
5.2.4 Key Strategies 18
5.3 Nutritionals 19
5.3.1 Overview 19
5.3.2 Financials 19
5.3.3 Market View 19
5.3.4 Key Strategies 19
5.4 Pharmaceuticals 19
5.4.1 Overview 19
5.4.2 Financials 19
5.4.3 Market View 19
5.4.4 Key Strategies 20
5.5 Vascular 20
5.5.1 Overview 20
5.5.2 Financials 20
5.5.3 Market View 20
5.5.4 Key Strategies 20
5.6 Major Products and Services 21
5.6.1 Overview 21
6 History 22
7 SWOT Analysis 27
7.1 Overview 27
7.2 Abbott Laboratories Strengths 28
7.2.1 Efficient Use of Resources 28
7.2.2 Strong Financial Performance 28
7.2.3 Diversified Geographic Presence 28
7.2.4 Diverse Product Portfolio 28
7.3 Abbott Laboratories Weaknesses 29
7.3.1 Product Recalls 29
7.3.2 Limited Liquidity Position 29
7.3.3 Legal Proceedings 29
7.4 Abbott Laboratories Opportunities 30
7.4.1 Expansion 30
7.4.2 Growing Aged Population 30
7.4.3 Market Growth in Emerging Economies 30
7.4.4 Growing Blood Glucose Monitoring Market 30
7.4.5 Strategic Acquisitions 31
7.5 Abbott Laboratories Threats 31
7.5.1 Increased Pricing Control 31
7.5.2 Tightening of the FDA’s Regulatory Oversight 31
7.5.3 Competitive Landscape 31
7.5.4 Technological Changes 32
8 Competitors 33
9 Competitive Landscape 34
9.1 In Vitro Diagnostics, Global, Company Share (%), 2009 34
9.2 Cardiovascular Devices, Global, Company Share (%), 2009 36
9.3 Diabetes Care Devices, Global, Company Share (%), 2009 38
10 Abbott Laboratories Medical Equipment Market Share Analysis 40
10.1 Abbott Laboratories, Global, Market Share (2009) 40
10.2 Abbott Laboratories, Asia-Pacific, Market Share (2009) 42
10.2.1 Abbott Laboratories, Australia, Market Share (2009) 44
10.2.2 Abbott Laboratories, China, Market Share (2009) 46
10.2.3 Abbott Laboratories, India, Market Share (2009) 48
10.2.4 Abbott Laboratories, Japan, Market Share (2009) 50
10.2.5 Abbott Laboratories, Other Asia-Pacific, Market Share (2009) 52
10.3 Abbott Laboratories, Europe, Market Share (2009) 54
10.3.1 Abbott Laboratories, France, Market Share (2009) 56
10.3.2 Abbott Laboratories, Germany, Market Share (2009) 58
10.3.3 Abbott Laboratories, Italy, Market Share (2009) 60
10.3.4 Abbott Laboratories, Spain, Market Share (2009) 62
10.3.5 Abbott Laboratories, United Kingdom, Market Share (2009) 64
10.3.6 Abbott Laboratories, Other Europe, Market Share (2009) 66
10.4 Abbott Laboratories, Middle East and Africa, Market Share (2009) 68
10.5 Abbott Laboratories, North America, Market Share (2009) 70
10.5.1 Abbott Laboratories, Canada, Market Share (2009) 72
10.5.2 Abbott Laboratories, United States, Market Share (2009) 74
10.6 Abbott Laboratories, South and Central America, Market Share (2009) 76
10.6.1 Abbott Laboratories, Brazil, Market Share (2009) 78
10.6.2 Abbott Laboratories, Other South and Central America, Market Share (2009) 80
11 Abbott Laboratories Medical Equipment Market Share Analysis by Category 82
11.1 Abbott Laboratories, Global, Category Revenue Share (2009) 82
11.2 Abbott Laboratories, Asia-Pacific, Category Revenue Share (2009) 85
11.2.1 Abbott Laboratories, Australia, Category Revenue Share (2009) 88
11.2.2 Abbott Laboratories, China, Category Revenue Share (2009) 91
11.2.3 Abbott Laboratories, India, Category Revenue Share (2009) 94
11.2.4 Abbott Laboratories, Japan, Category Revenue Share (2009) 97
11.2.5 Abbott Laboratories, Other Asia-Pacific, Category Revenue Share (2009) 100
11.3 Abbott Laboratories, Europe, Category Revenue Share (2009) 103
11.3.1 Abbott Laboratories, France, Category Revenue Share (2009) 106
11.3.2 Abbott Laboratories, Germany, Category Revenue Share (2009) 109
11.3.3 Abbott Laboratories, Italy, Category Revenue Share (2009) 112
11.3.4 Abbott Laboratories, Spain, Category Revenue Share (2009) 115
11.3.5 Abbott Laboratories, United Kingdom, Category Revenue Share (2009) 118
11.3.6 Abbott Laboratories, Other Europe, Category Revenue Share (2009) 121
11.4 Abbott Laboratories, Middle East and Africa, Category Revenue Share (2009) 124
11.5 Abbott Laboratories, North America, Category Revenue Share (2009) 127
11.5.1 Abbott Laboratories, Canada, Category Revenue Share (2009) 130
11.5.2 Abbott Laboratories, United States, Category Revenue Share (2009) 133
11.6 Abbott Laboratories, South and Central America, Category Revenue Share (2009) 136
11.6.1 Abbott Laboratories, Brazil, Category Revenue Share (2009) 139
11.6.2 Abbott Laboratories, Other South and Central America, Category Revenue Share (2009) 142
12 Key Employees 145
13 Key Employee Biographies 147
14 Company Statement 148
15 Locations And Subsidiaries 151
15.1 Head Office 151
15.2 Other Locations & Subsidiaries 151
16 Financial Deals Landscape 154
16.1 Abbott Laboratories, Deals Volume Summary, 2005 to YTD 2010 154
17 Abbott Laboratories Detailed Deal Summary 158
17.1 Asset Purchase 158
17.1.1 Boston Scientific To Sell Pain Management Unit 158
17.2 Partnerships 160
17.2.1 Fujirebio Diagnostics Signs Licensing Agreement with Abbott Laboratories 160
17.2.2 Rubicon Genomics Enters Into An Agreement With Abbott Laboratories 161
17.3 Acquisition 162
17.3.1 Abbott Laboratories Acquires Evalve 162
17.3.2 Abbott Laboratories Completes Acquisition of Visiogen 164
18 Recent Developments 166
18.1 Strategy and Business Planning 166
18.1.1 May 05, 2010: Abbott Opens Asia-Pacific Nutrition Research And Development Center In Singapore 166
18.1.2 Nov 17, 2009: Abbott Signs Agreement With BG Medicine For Development Of Heart Failure Test 166
18.1.3 Nov 15, 2009: Abbott Enters Into Agreement With PanGenetics 167
18.1.4 Nov 12, 2009: Abbott To Acquire PanGenetics BV's NGF Inhibitor To Treat Chronic Pain 167
18.1.5 Nov 12, 2009: Abbott To Acquire PanGenetics' Investigational Antibody To Treat Chronic Pain 167
18.1.6 Aug 27, 2009: Abbott Enters Into Agreement With Pfizer 168
18.1.7 Aug 18, 2009: Abbott Signs Partnership Agreement With Velcera For Pain Drug 168
18.2 Financial Announcements 169
18.2.1 Apr 21, 2010: Abbott Reports Net Earnings Of $1 Billion In Q1 2010 169
18.2.2 Jan 27, 2010: Abbott Reports Net Earnings Of $5.7 Million In 2009 169
18.2.3 Oct 14, 2009: Abbott Reports Net Earnings Of $1.5 Billion In Q3 2009 171
18.2.4 Oct 14, 2009: Abbott Q3 2009 Net Income Increases By 36.5% 172
18.3 Research and Development 173
18.3.1 Oct 23, 2009: Abbott Launches New R&D Facility At University of Illinois 173
18.4 Corporate Communications 173
18.4.1 Dec 03, 2009: Abbott Lays off about 80 Jobs at Its Temecula Factory, California 173
18.5 Legal and Regulatory 173
18.5.1 May 05, 2010: Watson Confirms SIMCOR Patent Challenge 173
18.5.2 Nov 11, 2009: Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 174
18.5.3 Aug 26, 2009: New Jersey Doctor Files Patent Lawsuit Against Abbott Over Heart Stents 174
18.6 Government and Public Interest 175
18.6.1 Apr 15, 2010: Abbott Begins Biopreparedness Evaluation Program with State Public Health Labs 175
18.6.2 Nov 17, 2009: FDA Warns Abbott on Manufacturing Practices At Des Plaines Facility 176
18.6.3 Nov 16, 2009: Federal Sales Tax on Medical Devices Would Cost Millions 176
18.6.4 Oct 20, 2009: FDA Grants 510(k) Clearance To Abbott For Cyclic-Citrulinated Peptide 176
18.6.5 Sep 14, 2009: SFDA Approves Abbott's XIENCE V Drug Eluting Stent 177
18.6.6 Sep 14, 2009: Abbott Obtains European Approval For Kaletra Tablet 177
18.6.7 Sep 14, 2009: Abbott Obtains European Approval For Once-daily Dosing of Kaletra Tablet 177
18.7 Product News 178
18.7.1 Jun 03, 2010: Abbott Receives FDA Clearance For ARCHITECT HE4 Assay 178
18.7.2 May 19, 2010: Abbott Receives BLA Approval From FDA For ABBOTT PRISM Chagas Test 178
18.7.3 Apr 30, 2010: Abbott Receives FDA Approval For Abbott Prism Chagas 179
18.7.4 Apr 30, 2010: FDA Announces Class II Recall Of Abbott’s Freestyle Navigator Continuous Glucose Monitor System 179
18.7.5 Feb 08, 2010: Abbott Files FDA 510(K) Application For ARCHITECT HE4 Assay 179
18.7.6 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 180
18.7.7 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 180
18.7.8 Sep 15, 2009: Abbott Gains Top Honor In Wall Street Journal Technology Innovation Awards for Its PLEX-ID 180
18.8 Product Approvals 181
18.8.1 Jun 03, 2010: Abbott Receives FDA Clearance For ARCHITECT HE4 Assay 181
18.8.2 May 19, 2010: Abbott Receives BLA Approval From FDA For ABBOTT PRISM Chagas Test 182
18.8.3 Apr 30, 2010: Abbott Receives FDA Approval For Abbott Prism Chagas 182
18.8.4 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 182
18.8.5 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 184
18.9 Other Significant Developments 184
18.9.1 Jan 13, 2010: Abbott to Provide $1 Million In Funding, Products To Help Address Health Needs In Haiti 184
18.9.2 Nov 02, 2009: Abbott Saves 1 Billion Gallons of Water Annually 185
18.9.3 Oct 14, 2009: Abbott Reports 36.5% Surge in Q3 Earnings 186
18.9.4 Sep 16, 2009: Abbott Expands Use Of Sustainable Packaging As Part Of Global Environmental Efforts 186
19 Appendix 188
19.1 Research Methodology 189
19.2 Secondary Research 190
19.3 Primary Research 190
19.4 Models 191
19.5 Forecasts 191
19.6 Expert Panels 191
19.7 GlobalData Consulting 191
19.8 Currency Conversion 192
19.9 Contact Us 193
19.10 Disclaimer 193
[Inhaltsverzeichnis ausblenden]

LIST OF TABLES

1.1 List of Tables
Table 1: Abbott Laboratories, Key Facts, 2009 17
Table 2: Abbott Laboratories, SWOT Analysis, 2009 27
Table 3: In Vitro Diagnostics, Global, Company Share by Revenue ($m), 2009 35
Table 4: Cardiovascular Devices, Global, Company Share by Revenue ($m), 2009 37
Table 5: Diabetes Care Devices, Global, Company Share by Revenue ($m), 2009 39
Table 6: Abbott Laboratories, Medical Equipment, Global, Revenue ($m) and Market Share (%), 2009 41
Table 7: Abbott Laboratories, Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%), 2009 43
Table 8: Abbott Laboratories, Medical Equipment, Australia, Revenue ($m) and Market Share (%), 2009 45
Table 9: Abbott Laboratories, Medical Equipment, China, Revenue ($m) and Market Share (%), 2009 47
Table 10: Abbott Laboratories, Medical Equipment, India, Revenue ($m) and Market Share (%), 2009 49
Table 11: Abbott Laboratories, Medical Equipment, Japan, Revenue ($m) and Market Share (%), 2009 51
Table 12: Abbott Laboratories, Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%), 2009 53
Table 13: Abbott Laboratories, Medical Equipment, Europe, Revenue ($m) and Market Share (%), 2009 55
Table 14: Abbott Laboratories, Medical Equipment, France, Revenue ($m) and Market Share (%), 2009 57
Table 15: Abbott Laboratories, Medical Equipment, Germany, Revenue ($m) and Market Share (%), 2009 59
Table 16: Abbott Laboratories, Medical Equipment, Italy, Revenue ($m) and Market Share (%), 2009 61
Table 17: Abbott Laboratories, Medical Equipment, Spain, Revenue ($m) and Market Share (%), 2009 63
Table 18: Abbott Laboratories, Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%), 2009 65
Table 19: Abbott Laboratories, Medical Equipment, Other Europe, Revenue ($m) and Market Share (%), 2009 67
Table 20: Abbott Laboratories, Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%), 2009 69
Table 21: Abbott Laboratories, Medical Equipment, North America, Revenue ($m) and Market Share (%), 2009 71
Table 22: Abbott Laboratories, Medical Equipment, Canada, Revenue ($m) and Market Share (%), 2009 73
Table 23: Abbott Laboratories, Medical Equipment, United States, Revenue ($m) and Market Share (%), 2009 75
Table 24: Abbott Laboratories, Medical Equipment, South and Central America, Revenue ($m) and Market Share (%), 2009 77
Table 25: Abbott Laboratories, Medical Equipment, Brazil, Revenue ($m) and Market Share (%), 2009 79
Table 26: Abbott Laboratories, Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%), 2009 81
Table 27: Abbott Laboratories, Medical Equipment, Global, Revenue ($m) and Market Share (%) by Category, 2009 84
Table 28: Abbott Laboratories, Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 87
Table 29: Abbott Laboratories, Medical Equipment, Australia, Revenue ($m) and Market Share (%) by Category, 2009 90
Table 30: Abbott Laboratories, Medical Equipment, China, Revenue ($m) and Market Share (%) by Category, 2009 93
Table 31: Abbott Laboratories, Medical Equipment, India, Revenue ($m) and Market Share (%) by Category, 2009 96
Table 32: Abbott Laboratories, Medical Equipment, Japan, Revenue ($m) and Market Share (%) by Category, 2009 99
Table 33: Abbott Laboratories, Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 102
Table 34: Abbott Laboratories, Medical Equipment, Europe, Revenue ($m) and Market Share (%) by Category, 2009 105
Table 35: Abbott Laboratories, Medical Equipment, France, Revenue ($m) and Market Share (%) by Category, 2009 108
Table 36: Abbott Laboratories, Medical Equipment, Germany, Revenue ($m) and Market Share (%) by Category, 2009 111
Table 37: Abbott Laboratories, Medical Equipment, Italy, Revenue ($m) and Market Share (%) by Category, 2009 114
Table 38: Abbott Laboratories, Medical Equipment, Spain, Revenue ($m) and Market Share (%) by Category, 2009 117
Table 39: Abbott Laboratories, Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2009 120
Table 40: Abbott Laboratories, Medical Equipment, Other Europe, Revenue ($m) and Market Share (%) by Category, 2009 123
Table 41: Abbott Laboratories, Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2009 126
Table 42: Abbott Laboratories, Medical Equipment, North America, Revenue ($m) and Market Share (%) by Category, 2009 129
Table 43: Abbott Laboratories, Medical Equipment, Canada, Revenue ($m) and Market Share (%) by Category, 2009 132
Table 44: Abbott Laboratories, Medical Equipment, United States, Revenue ($m) and Market Share (%) by Category, 2009 135
Table 45: Abbott Laboratories, Medical Equipment, South and Central America, Revenue ($m) and Market Share (%) by Category, 2009 138
Table 46: Abbott Laboratories, Medical Equipment, Brazil, Revenue ($m) and Market Share (%) by Category, 2009 141
Table 47: Abbott Laboratories, Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2009 144
Table 48: Abbott Laboratories, Key Employees 145
Table 49: Abbott Laboratories, Other Locations 151
Table 50: Abbott Laboratories, Subsidiaries 152
Table 51: Abbott Laboratories, Deals Volume Summary, 2005 to YTD 2010 154
Table 52: Abbott Laboratories, Deals Summary, 2005 to YTD 2010 155
Table 53: Boston Scientific To Sell Pain Management Unit 158
Table 54: Fujirebio Diagnostics Signs Licensing Agreement With Abbott Laboratories 160
Table 55: Rubicon Genomics Enters Into An Agreement With Abbott Laboratories 161
Table 56: Abbott Laboratories Acquires Evalve 162
Table 57: Abbott Laboratories Completes Acquisition Of Visiogen 164
Table 58: USD to Local Currency, Average Exchange Rate 2009 192
LIST OF FIGURES

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Global, Company Share (%), 2009 34
Figure 2: Cardiovascular Devices, Global, Company Share (%), 2009 36
Figure 3: Diabetes Care Devices, Global, Company Share (%), 2009 38
Figure 4: Abbott Laboratories, Medical Equipment, Global, Revenue Share (%), 2009 40
Figure 5: Abbott Laboratories, Medical Equipment, Global, Market Share (%), 2009 41
Figure 6: Abbott Laboratories, Medical Equipment, Asia-Pacific, Revenue Share (%), 2009 42
Figure 7: Abbott Laboratories, Medical Equipment, Asia-Pacific, Market Share (%), 2009 43
Figure 8: Abbott Laboratories, Medical Equipment, Australia, Revenue Share (%), 2009 44
Figure 9: Abbott Laboratories, Medical Equipment, Australia, Market Share (%), 2009 45
Figure 10: Abbott Laboratories, Medical Equipment, China, Revenue Share (%), 2009 46
Figure 11: Abbott Laboratories, Medical Equipment, China, Market Share (%), 2009 47
Figure 12: Abbott Laboratories, Medical Equipment, India, Revenue Share (%), 2009 48
Figure 13: Abbott Laboratories, Medical Equipment, India, Market Share (%), 2009 49
Figure 14: Abbott Laboratories, Medical Equipment, Japan, Revenue Share (%), 2009 50
Figure 15: Abbott Laboratories, Medical Equipment, Japan, Market Share (%), 2009 51
Figure 16: Abbott Laboratories, Medical Equipment, Other Asia-Pacific, Revenue Share (%), 2009 52
Figure 17: Abbott Laboratories, Medical Equipment, Other Asia-Pacific, Market Share (%), 2009 53
Figure 18: Abbott Laboratories, Medical Equipment, Europe, Revenue Share (%), 2009 54
Figure 19: Abbott Laboratories, Medical Equipment, Europe, Market Share (%), 2009 55
Figure 20: Abbott Laboratories, Medical Equipment, France, Revenue Share (%), 2009 56
Figure 21: Abbott Laboratories, Medical Equipment, France, Market Share (%), 2009 57
Figure 22: Abbott Laboratories, Medical Equipment, Germany, Revenue Share (%), 2009 58
Figure 23: Abbott Laboratories, Medical Equipment, Germany, Market Share (%), 2009 59
Figure 24: Abbott Laboratories, Medical Equipment, Italy, Revenue Share (%), 2009 60
Figure 25: Abbott Laboratories, Medical Equipment, Italy, Market Share (%), 2009 61
Figure 26: Abbott Laboratories, Medical Equipment, Spain, Revenue Share (%), 2009 62
Figure 27: Abbott Laboratories, Medical Equipment, Spain, Market Share (%), 2009 63
Figure 28: Abbott Laboratories, Medical Equipment, United Kingdom, Revenue Share (%), 2009 64
Figure 29: Abbott Laboratories, Medical Equipment, United Kingdom, Market Share (%), 2009 65
Figure 30: Abbott Laboratories, Medical Equipment, Other Europe, Revenue Share (%), 2009 66
Figure 31: Abbott Laboratories, Medical Equipment, Other Europe, Market Share (%), 2009 67
Figure 32: Abbott Laboratories, Medical Equipment, Middle East and Africa, Revenue Share (%), 2009 68
Figure 33: Abbott Laboratories, Medical Equipment, Middle East and Africa, Market Share (%), 2009 69
Figure 34: Abbott Laboratories, Medical Equipment, North America, Revenue Share (%), 2009 70
Figure 35: Abbott Laboratories, Medical Equipment, North America, Market Share (%), 2009 71
Figure 36: Abbott Laboratories, Medical Equipment, Canada, Revenue Share (%), 2009 72
Figure 37: Abbott Laboratories, Medical Equipment, Canada, Market Share (%), 2009 73
Figure 38: Abbott Laboratories, Medical Equipment, United States, Revenue Share (%), 2009 74
Figure 39: Abbott Laboratories, Medical Equipment, United States, Market Share (%), 2009 75
Figure 40: Abbott Laboratories, Medical Equipment, South and Central America, Revenue Share (%), 2009 76
Figure 41: Abbott Laboratories, Medical Equipment, South and Central America, Market Share (%), 2009 77
Figure 42: Abbott Laboratories, Medical Equipment, Brazil, Revenue Share (%), 2009 78
Figure 43: Abbott Laboratories, Medical Equipment, Brazil, Market Share (%), 2009 79
Figure 44: Abbott Laboratories, Medical Equipment, Other South and Central America, Revenue Share (%), 2009 80
Figure 45: Abbott Laboratories, Medical Equipment, Other South and Central America, Market Share (%), 2009 81
Figure 46: Abbott Laboratories, Medical Equipment, Global, Category Revenue Share (%), 2009 82
Figure 47: Abbott Laboratories, Medical Equipment, Global, Market Share (%) by Category, 2009 83
Figure 48: Abbott Laboratories, Medical Equipment, Asia-Pacific, Category Revenue Share (%), 2009 85
Figure 49: Abbott Laboratories, Medical Equipment, Asia-Pacific, Market Share (%) by Category, 2009 86
Figure 50: Abbott Laboratories, Medical Equipment, Australia, Category Revenue Share (%), 2009 88
Figure 51: Abbott Laboratories, Medical Equipment, Australia, Market Share (%) by Category, 2009 89
Figure 52: Abbott Laboratories, Medical Equipment, China, Category Revenue Share (%), 2009 91
Figure 53: Abbott Laboratories, Medical Equipment, China, Market Share (%) by Category, 2009 92
Figure 54: Abbott Laboratories, Medical Equipment, India, Category Revenue Share (%), 2009 94
Figure 55: Abbott Laboratories, Medical Equipment, India, Market Share (%) by Category, 2009 95
Figure 56: Abbott Laboratories, Medical Equipment, Japan, Category Revenue Share (%), 2009 97
Figure 57: Abbott Laboratories, Medical Equipment, Japan, Market Share (%) by Category, 2009 98
Figure 58: Abbott Laboratories, Medical Equipment, Other Asia-Pacific, Category Revenue Share (%), 2009 100
Figure 59: Abbott Laboratories, Medical Equipment, Other Asia-Pacific, Market Share (%) by Category, 2009 101
Figure 60: Abbott Laboratories, Medical Equipment, Europe, Category Revenue Share (%), 2009 103
Figure 61: Abbott Laboratories, Medical Equipment, Europe, Market Share (%) by Category, 2009 104
Figure 62: Abbott Laboratories, Medical Equipment, France, Category Revenue Share (%), 2009 106
Figure 63: Abbott Laboratories, Medical Equipment, France, Market Share (%) by Category, 2009 107
Figure 64: Abbott Laboratories, Medical Equipment, Germany, Category Revenue Share (%), 2009 109
Figure 65: Abbott Laboratories, Medical Equipment, Germany, Market Share (%) by Category, 2009 110
Figure 66: Abbott Laboratories, Medical Equipment, Italy, Category Revenue Share (%), 2009 112
Figure 67: Abbott Laboratories, Medical Equipment, Italy, Market Share (%) by Category, 2009 113
Figure 68: Abbott Laboratories, Medical Equipment, Spain, Category Revenue Share (%), 2009 115
Figure 69: Abbott Laboratories, Medical Equipment, Spain, Market Share (%) by Category, 2009 116
Figure 70: Abbott Laboratories, Medical Equipment, United Kingdom, Category Revenue Share (%), 2009 118
Figure 71: Abbott Laboratories, Medical Equipment, United Kingdom, Market Share (%) by Category, 2009 119
Figure 72: Abbott Laboratories, Medical Equipment, Other Europe, Category Revenue Share (%), 2009 121
Figure 73: Abbott Laboratories, Medical Equipment, Other Europe, Market Share (%) by Category, 2009 122
Figure 74: Abbott Laboratories, Medical Equipment, Middle East and Africa, Category Revenue Share (%), 2009 124
Figure 75: Abbott Laboratories, Medical Equipment, Middle East and Africa, Market Share (%) by Category, 2009 125
Figure 76: Abbott Laboratories, Medical Equipment, North America, Category Revenue Share (%), 2009 127
Figure 77: Abbott Laboratories, Medical Equipment, North America, Market Share (%) by Category, 2009 128
Figure 78: Abbott Laboratories, Medical Equipment, Canada, Category Revenue Share (%), 2009 130
Figure 79: Abbott Laboratories, Medical Equipment, Canada, Market Share (%) by Category, 2009 131
Figure 80: Abbott Laboratories, Medical Equipment, United States, Category Revenue Share (%), 2009 133
Figure 81: Abbott Laboratories, Medical Equipment, United States, Market Share (%) by Category, 2009 134
Figure 82: Abbott Laboratories, Medical Equipment, South and Central America, Category Revenue Share (%), 2009 136
Figure 83: Abbott Laboratories, Medical Equipment, South and Central America, Market Share (%) by Category, 2009 137
Figure 84: Abbott Laboratories, Medical Equipment, Brazil, Category Revenue Share (%), 2009 139
Figure 85: Abbott Laboratories, Medical Equipment, Brazil, Market Share (%) by Category, 2009 140
Figure 86: Abbott Laboratories, Medical Equipment, Other South and Central America, Category Revenue Share (%), 2009 142
Figure 87: Abbott Laboratories, Medical Equipment, Other South and Central America, Market Share (%) by Category, 2009 143
Figure 88: Abbott Laboratories, Deals Volume Summary, 2005 to YTD 2010 154
Figure 89: GlobalData Methodology 189
[Tabellenverzeichnis ausblenden]